{"entity":{"id":"immunitor","kind":"company","name":"Immunitor","aka":["Immunitor LLC","Immunitor Inc."],"tldr":"Immunitor is a Mongolian biotech, founded in 2000, that makes oral tablet vaccines from heat-inactivated cells; its hepatocellular carcinoma vaccine hepcortespenlisimut-L went through phase 3 trials the company led.","summary":"Immunitor, based in Ulaanbaatar and founded in 2000, develops oral tablet immunotherapies made from heat-inactivated cells, including a tuberculosis vaccine and hepcortespenlisimut-L (V5) for hepatocellular carcinoma, which it tested in phase 3 trials in Mongolia registered on ClinicalTrials.gov under Immunitor as lead sponsor.","asOf":"2026-09-11","links":[{"label":"Official website","url":"http://www.immunitor.mn"},{"label":"ClinicalTrials.gov: trials led by Immunitor LLC","url":"https://clinicaltrials.gov/search?lead=Immunitor%20LLC"},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q50039606"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["hcc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Ulaanbaatar","country":"MN","companyType":"biotech","website":"http://www.immunitor.mn","founded":2000,"stage":"private-large","investors":[],"funding":[]},"route":"/companies/immunitor/","neighbours":{"cancer":[{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}